Your browser doesn't support javascript.
loading
Should we really include systemic sclerosis specific antibodies in the classification criteria of Sjogren's disease?
Zimmermann, François; Robin, François; Cadiou, Simon; Belhomme, Nicolas; Jégo, Patrick; Coiffier, Guillaume; Lescoat, Alain.
Afiliación
  • Zimmermann F; Department of Internal Medicine, CHU Rennes, University of Rennes 1, Rennes, France. Electronic address: francois.zimmermann@chu-rennes.fr.
  • Robin F; Department of Rheumatology, CHU Rennes, University of Rennes 1, Rennes, France; INSERM, Rennes University Hospital, UMR 1241, Institut NuMeCan (Nutrition Metabolisms and Cancer), University Rennes, France.
  • Cadiou S; Department of Rheumatology, CHU Rennes, University of Rennes 1, Rennes, France.
  • Belhomme N; Department of Internal Medicine, CHU Rennes, University of Rennes 1, Rennes, France; Department of Rheumatology, CHU Rennes, University of Rennes 1, Rennes, France; INSERM, Rennes University Hospital, UMR 1241, Institut NuMeCan (Nutrition Metabolisms and Cancer), University Rennes, France; CHU Renne
  • Jégo P; Department of Internal Medicine, CHU Rennes, University of Rennes 1, Rennes, France; Department of Rheumatology, CHU Rennes, University of Rennes 1, Rennes, France; INSERM, Rennes University Hospital, UMR 1241, Institut NuMeCan (Nutrition Metabolisms and Cancer), University Rennes, France; CHU Renne
  • Coiffier G; Department of Internal Medicine, CHU Rennes, University of Rennes 1, Rennes, France; Department of Rheumatology, CHU Rennes, University of Rennes 1, Rennes, France; INSERM, Rennes University Hospital, UMR 1241, Institut NuMeCan (Nutrition Metabolisms and Cancer), University Rennes, France; CHU Renne
  • Lescoat A; Department of Internal Medicine, CHU Rennes, University of Rennes 1, Rennes, France; Department of Rheumatology, CHU Rennes, University of Rennes 1, Rennes, France; INSERM, Rennes University Hospital, UMR 1241, Institut NuMeCan (Nutrition Metabolisms and Cancer), University Rennes, France; CHU Renne
Semin Arthritis Rheum ; 58: 152158, 2023 02.
Article en En | MEDLINE | ID: mdl-36580854
We have read with great interest the results from Marketos et al. regarding the positivity of specific systemic sclerosis auto-antibodies in patients with sicca symptoms. Based on complementary data from the literature, we rather believe scleroderma-associated antibodies should be considered either as a yellow flag for an association between scleroderma and Sjogren, or a potential undiagnosed scleroderma, rather than an isolated Sjogren's disease.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Síndrome de Sjögren Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Semin Arthritis Rheum Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Síndrome de Sjögren Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Semin Arthritis Rheum Año: 2023 Tipo del documento: Article